Expertise in
27
conditions

Dr. Percy P. Lee

Radiation Oncology
Percy Lee, M.D.
Irvine, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
27
conditions
Percy Lee, M.D.
Irvine, CA 

Overview

Percy Lee is a Radiation Oncologist practicing medicine in Irvine, California.

Dr. Lee is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Tissue Biopsy, and Liver Embolization.

He is actively involved in clinical research, co-authoring 209 peer reviewed articles and participating in 8 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Percy Lee, M.D.
Irvine, CA 92618

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Local Consolidative Therapy (LCT) and Durvalumab (MEDI4736) for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy (ENDURE)
Local Consolidative Therapy (LCT) and Durvalumab (MEDI4736) for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy (ENDURE)
Enrollment Status: Recruiting
Publish Date: September 03, 2026
Intervention Type: Drug, Biological, Procedure, Other
Study Drugs: Carboplatin, Durvalumab, Gemcitabine, Nab-paclitaxel, Paclitaxel, Pemetrexed
Study Phase: Phase 2
Randomized Phase I/II Study of Ablative Radiotherapy +/- MEDI 4736 (Durvalumab) for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
Randomized Phase I/II Study of Ablative Radiotherapy +/- MEDI 4736 (Durvalumab) for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: July 16, 2026
Intervention Type: Drug, Radiation
Study Drug: Durvalumab
Study Phase: Phase 1/Phase 2
Image-Guided Hypofractionated Radiotherapy With Stereotactic Boost and Chemotherapy for Inoperable Stage II-III Non-Small Cell Lung Cancer
Image-Guided Hypofractionated Radiotherapy With Stereotactic Boost and Chemotherapy for Inoperable Stage II-III Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 25, 2026
Intervention Type: Radiation, Other, Drug
Study Phase: Not Applicable
Stereotactic Body Radiotherapy for Liver Metastases and Hepatocellular Carcinoma Utilizing an MRI-Guided Tri-60Co Teletherapy System
Stereotactic Body Radiotherapy for Liver Metastases and Hepatocellular Carcinoma Utilizing an MRI-Guided Tri-60Co Teletherapy System
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Radiation
Study Phase: Early Phase 1
Gene Expression That Predicts Radiation Exposure in Humans
Gene Expression That Predicts Radiation Exposure in Humans
Enrollment Status: Completed
Publish Date: April 21, 2021
Neoadjuvant Accelerated Hypofractionated Radiation Therapy Immediately Prior to Radical Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Pilot Study
Neoadjuvant Accelerated Hypofractionated Radiation Therapy Immediately Prior to Radical Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Pilot Study
Enrollment Status: Terminated
Publish Date: July 24, 2020
Intervention Type: Radiation, Other, Procedure
Study Phase: Not Applicable
A Randomized Controlled Phase II Study of Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies
A Randomized Controlled Phase II Study of Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies
Enrollment Status: Terminated
Publish Date: April 03, 2019
Intervention Type: Device, Other
Study Phase: Phase 2
View 6 Less Clinical Trials

209 Total Publications

Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Adjuvant Therapy for Resected Adenocarcinoma of the Pancreas.
Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Adjuvant Therapy for Resected Adenocarcinoma of the Pancreas.
Journal: American journal of clinical oncology
Published: August 20, 2026
Similar Doctors
Expertise in
21
conditions
Dr. Mitchell R. Kamrava
Radiation Oncology
Expertise in
21
conditions
Dr. Mitchell R. Kamrava
Radiation Oncology
Referral may be required

Cedars-Sinai Radiation Oncology-Los Angeles

8720 Beverly Blvd, 
West Hollywood, CA 
 (46.7 miles away)
310-423-4208
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mitchell Kamrava is a Radiation Oncologist practicing medicine in West Hollywood, California. Dr. Kamrava is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Vaginal Cancer, Prostate Cancer, Prostatectomy, and Vitrectomy.

Expertise in
32
conditions
Dr. Arya R. Amini
Radiation Oncology
Expertise in
32
conditions
Dr. Arya R. Amini
Radiation Oncology
Referral may be required

Arya Amini, M.D.

1500 Duarte Rd, 
Duarte, CA 
 (34.8 miles away)
800-826-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arya Amini is a Radiation Oncologist practicing medicine in Duarte, California. Dr. Amini is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Glossectomy, and Penectomy.

Expertise in
17
conditions
Dr. Amanda L. Schwer
Radiation Oncology
Expertise in
17
conditions
Dr. Amanda L. Schwer
Radiation Oncology
Referral may be required

Amanda Schwer, M.D.

Irvine, CA 
 (0.1 miles away)
847-342-6842
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Amanda Schwer is a Radiation Oncologist practicing medicine in Irvine, California. Dr. Schwer is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Breast Cancer, and Lung Adenocarcinoma.

Frequently Asked Questions about Dr. Percy P. Lee

How do I make an appointment with Dr. Percy P. Lee?

You can book an appointment with Dr. Percy P. Lee by calling their office at 847-342-6842. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Percy P. Lee a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Percy P. Lee is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Percy P. Lee specialize in?

While Dr. Percy P. Lee is a Radiation Oncology, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Percy P. Lee participate in research or clinical trials?

Yes. Dr. Percy P. Lee has published 209 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Percy P. Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Percy P. Lee accept my insurance?

Dr. Percy P. Lee accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-342-6842 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lee's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 15 Advanced Conditions
View All 55 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile